Recent Updates
Recently added Catalysts
EBS Positive Sentiment

Emergent BioSolutions to Release First Quarter 2023 Financial Results and Conduct Conference Call on May 9, 2023

Wednesday, April 19, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Emergent BioSolutions Inc. will hold a conference call on May 9, 2023, to discuss its first quarter 2023 financial results. During the call, the company will also cover recent business developments and provide revenue guidance for the second quarter and full year. This event highlights the company's commitment to keeping its investors informed about its financial health and prospects.
Price reaction · baseline $10.94 (2023-04-18 close) · hit after-hours · clean, no other EBS news in the window
day 0 close · peak
-2.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Emergent BioSolutions is proactively updating investors on financial performance.
  • The scheduled conference call indicates transparency and shareholder engagement.
  • Revenue guidance provided for the coming quarters suggests optimistic outlook.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+70%
120-day peak, hindsight
Typical move
8%
average across 2 past catalysts
Lead asset
FLU-IGIV
Phase 2 · Influenza A H3N2

Full Press Release Details

GAITHERSBURG, Md., April 19, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Tuesday, May 9, 2023, at 5:00 pm eastern time to discuss the financial results for the first quarter of 2023, recent business developments, revenue guidance for the second quarter of 2023, and financial outlook for full year 2023.
Conference Call Information
Participants can access the conference call live via webcast from the Investors page of Emergent’s website. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call.
A replay of the call can be accessed from the Investors page of Emergent’s website.
About Emergent BioSolutions
Vice President, Investor Relations
Senior Director, Media Relations

Frequently Asked Questions

When is Emergent BioSolutions' conference call?

The conference call is on May 9, 2023, at 5:00 pm eastern time.

How can I access the conference call?

You can join via the webcast on Emergent’s Investors page or by telephone.

What will be discussed in the conference call?

The call will cover Q1 2023 financial results and revenue guidance for Q2 2023.

Where can I find the replay of the call?

A replay will be available on the Investors page of Emergent’s website.

ShareAdd on Google
Tags: EBS Viatris Investor Conferences Healthcare Emergent BioSolutions Q1 2023 earnings conference call revenue guidance financial results
Last updated: Apr 19, 2023

Biotech snapshot

Cash runway
$141M liquidity · $0M/mo burn
Low dilution risk
Lead asset
FLU-IGIVPhase 2
Influenza A H3N2 →

Catalyst track record

+70%
best trade around EBS's most recent catalyst

Peak hindsight return over a 120-day window, across 2 tracked FDA/PDUFA catalysts for EBS.

See every catalyst's timing & PoA →